Literature DB >> 3341657

Stopping antibiotic therapy in neutropenic patients.

M J DiNubile1.   

Abstract

Infection is the major cause of death in neutropenic patients. Because of the lack of acute inflammatory cells, the usual signs of infection are often absent in these patients. Therefore, unexplained fever in a neutropenic patient requires prompt initiation of antibiotic therapy. Many physicians advocate continuing antibiotic therapy until neutropenia resolves. However, prolonged treatment with broad-spectrum antibiotics increases the risks of drug toxicity and superinfection with resistant bacteria and fungi. Based on a critical review of the literature and a large personal clinical experience, I offer tentative guidelines for withdrawing antibiotic therapy in persistently neutropenic patients. When antibiotic therapy is discontinued, frequent and careful monitoring of these patients and a low threshold for reinstituting antibiotic therapy are essential.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341657     DOI: 10.7326/0003-4819-108-2-289

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

1.  Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.

Authors:  M Nobbenhuis; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 2.  Infections in neutropenic patients. II: Management.

Authors:  P Engervall; M Björkholm
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

3.  Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination.

Authors:  S de Marie; P J van den Broek; R Willemze; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.